Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CCDC125 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCDC125 mRNA | CTD | PMID:22079256 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCDC125 mRNA | CTD | PMID:21215274 and PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ccdc125 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCDC125 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CCDC125 mRNA | CTD | PMID:30851411 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Ccdc125 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CCDC125 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CCDC125 mRNA | CTD | PMID:30047161 | aflatoxin B1 | increases methylation | ISO | CCDC125 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CCDC125 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | CCDC125 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of CCDC125 intron | CTD | PMID:30157460 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of CCDC125 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CCDC125 mRNA | CTD | PMID:33212167 | avobenzone | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | avobenzone results in decreased expression of CCDC125 mRNA | CTD | PMID:31016361 | azoxystrobin | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA | CTD | PMID:33854195 | benzo[a]pyrene | decreases expression | ISO | Ccdc125 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CCDC125 mRNA | CTD | PMID:22228805 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCDC125 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CCDC125 mRNA | CTD | PMID:36232920 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CCDC125 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | Ccdc125 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CCDC125 mRNA | CTD | PMID:33221593 | carbon nanotube | decreases expression | ISO | Ccdc125 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of CCDC125 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | CCDC125 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CCDC125 gene] | CTD | PMID:28238834 | chlorpyrifos | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA | CTD | PMID:33854195 | chromium(6+) | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of CCDC125 mRNA | CTD | PMID:30690063 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CCDC125 mRNA | CTD | PMID:24386269 | copper(II) sulfate | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CCDC125 mRNA | CTD | PMID:19549813 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of CCDC125 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CCDC125 mRNA | CTD | PMID:20106945 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of CCDC125 mRNA | CTD | PMID:29391264 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CCDC125 mRNA | CTD | PMID:33387578 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of CCDC125 mRNA | CTD | PMID:24136188 | glyphosate | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA | CTD | PMID:33854195 | imidacloprid | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA | CTD | PMID:33854195 | lipopolysaccharide | multiple interactions | ISO | CCDC125 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCDC125 mRNA | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of CCDC125 mRNA | CTD | PMID:35811015 | menadione | affects expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of CCDC125 mRNA | CTD | PMID:20044591 | methidathion | increases expression | ISO | Ccdc125 (Mus musculus) | 6480464 | methidathion results in increased expression of CCDC125 mRNA | CTD | PMID:34813904 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of CCDC125 mRNA | CTD | PMID:30047161 | paracetamol | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CCDC125 mRNA | CTD | PMID:29067470 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CCDC125 mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | increases expression | ISO | Ccdc125 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of CCDC125 mRNA | CTD | PMID:37995155 | potassium chromate | multiple interactions | ISO | CCDC125 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCDC125 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CCDC125 mRNA | CTD | PMID:22079256 and PMID:22714537 | rac-lactic acid | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CCDC125 mRNA | CTD | PMID:30851411 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CCDC125 mRNA | CTD | PMID:19013527 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CCDC125 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCDC125 mRNA | CTD | PMID:35811015 | temozolomide | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of CCDC125 mRNA | CTD | PMID:31758290 | thiabendazole | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA | CTD | PMID:33854195 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CCDC125 mRNA | CTD | PMID:34492290 | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of CCDC125 mRNA | CTD | PMID:21683754 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CCDC125 mRNA | CTD | PMID:33387578 | urethane | decreases expression | ISO | CCDC125 (Homo sapiens) | 6480464 | Urethane results in decreased expression of CCDC125 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Ccdc125 (Mus musculus) | 6480464 | Valproic Acid affects the expression of CCDC125 mRNA | CTD | PMID:17963808 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of CCDC125 mRNA | CTD | PMID:23034163 | |